Form 8-K - Current report:
SEC Accession No. 0001437749-17-017673
Filing Date
2017-10-26
Accepted
2017-10-26 16:29:35
Documents
8
Period of Report
2017-10-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tech20171026_8k.htm 8-K 53701
2 EXHIBIT 10.1 ex_97613.htm EX-10.1 141533
3 EXHIBIT 10.2 ex_97614.htm EX-10.2 40414
4 EXHIBIT 10.3 ex_97615.htm EX-10.3 48135
5 EXHIBIT 10.4 ex_97616.htm EX-10.4 51392
6 EXHIBIT 10.5 ex_97617.htm EX-10.5 31655
7 EXHIBIT 10.6 ex_97618.htm EX-10.6 39803
8 EXHIBIT 10.7 ex_97619.htm EX-10.7 41555
  Complete submission text file 0001437749-17-017673.txt   449393
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 171156645
SIC: 2836 Biological Products, (No Diagnostic Substances)